Prevalence in Northern India 1.

06%
(JGH, 2011)]

Par India prevalence 0.67% (AIG, 2015)

Ph
.D
Global prevalence 0.7% (CGH, 2019) Re . stu
s
de Ga ear den
i tu Global prevalence 0.67% (CGH, 2016) str ch ts,
n oe Sch Fel
a g a se nt ol lo
m se Asia-Pacific Study (Ongoing) er ar ws
i ng Di ol s
o g in &
fin the y
De of ng

Population
i
ain

studies
Tr

based
Gluten tested for gluten free National Biorepository
food 15% contaminated DBT Sponsored
Celiac Disease
Development of Adherence Gluten contamination team at AIIMS Creating Comprehensive care Unit
tool Infrastructure for Celiac Disease

Ongoing Improving Diagnostics

Research in 2019 of Celiac Disease

Biomarkers prediction for enteropathy Biopsies could be avoided

(JGH, 2019) in 78% of patients if level of
citrulline is ≤ 30 μM/L
NMR-Based Biomarker for enteropathy
(Under Review)

Variation in the performance of ELISA

kits of Anti-tTG Abs (CGH, 2019)

Development of Quantitative Histology-

based classification for grading of
severity of villous abnormalities
(Under Review)